Tolerability of Meropenem and Ertapenem in a Patient with Documented Delayed Hypersensitivity Reaction to Imipenem–Cilastatin: A Literature Review

Bakır P , Kara E , Yalçın A , et al. Cross-reactivity to meropenem and ertapenem without imipenem. J Crit Intensive Care, 2020; doi: 10.37678/dcybd.2020.2153

Chen Z , Baur X , Kutscha-Lissberg F , Merget R . IgE-mediated anaphylactic reaction to imipenem. Allergy, 2000; 55(1):92–93; doi: 10.1034/j.1398-9995.2000.00360.x

Bauer SL , Wall GC , Skoglund KJ , Peters LK . Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin. J Allergy Clin Immunol, 2004; 113(1):173–175; doi: 10.1016/j.jaci.2003.10.055

Lakhal K , Lortat-Jacob B , Neukirch C , et al. Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem. Pharmacother J Hum Pharmacol Drug Ther, 2007; 27(9):1334–1338; doi: 10.1592/phco.27.9.1334

Noguerado-Mellado B , Pinto Fernández C , Pineda-Pineda R , et al. Cross-reactivity between carbapenems: Two case reports. J Allergy Clin Immunol Pract, 2014; 2(6):816–817; doi: 10.1016/j.jaip.2014.06.015

Gil-Serrano J , Cardona V , Luengo O , et al. Anaphylactic shock to meropenem with ertapenem tolerance: A case report. J Allergy Clin Immunol Pract, 2019; 7(6):2057–2058; doi: 10.1016/j.jaip.2019.01.052